These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

857 related articles for article (PubMed ID: 34375696)

  • 1. Myocarditis and Pericarditis After COVID-19 mRNA Vaccination: Practical Considerations for Care Providers.
    Luk A; Clarke B; Dahdah N; Ducharme A; Krahn A; McCrindle B; Mizzi T; Naus M; Udell JA; Virani S; Zieroth S; McDonald M
    Can J Cardiol; 2021 Oct; 37(10):1629-1634. PubMed ID: 34375696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
    Pillay J; Gaudet L; Wingert A; Bialy L; Mackie AS; Paterson DI; Hartling L
    BMJ; 2022 Jul; 378():e069445. PubMed ID: 35830976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
    Gargano JW; Wallace M; Hadler SC; Langley G; Su JR; Oster ME; Broder KR; Gee J; Weintraub E; Shimabukuro T; Scobie HM; Moulia D; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(27):977-982. PubMed ID: 34237049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pericarditis and myocarditis after COVID-19 mRNA vaccination in a nationwide setting.
    Yap J; Tham MY; Poh J; Toh D; Chan CL; Lim TW; Lim SL; Chia YW; Lim YT; Choo J; Ding ZP; Foo LL; Kuo S; Lau YH; Lee A; Yeo KK
    Ann Acad Med Singap; 2022 Feb; 51(2):96-100. PubMed ID: 35224605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Myocarditis and Pericarditis After mRNA COVID-19 Vaccinations-A Single-Centre Retrospective Analysis.
    Wassif M; Lo P; Satouris P; Swan L; Tardo D; Kovacic JC; Muller D; Muthiah K; Kotlyar E; Bart NK
    Heart Lung Circ; 2023 Apr; 32(4):467-479. PubMed ID: 36841638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 vaccination and cardiac dysfunction.
    Leowattana W; Leowattana T
    World J Cardiol; 2022 Jun; 14(6):343-354. PubMed ID: 35979182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series.
    Fazlollahi A; Zahmatyar M; Noori M; Nejadghaderi SA; Sullman MJM; Shekarriz-Foumani R; Kolahi AA; Singh K; Safiri S
    Rev Med Virol; 2022 Jul; 32(4):e2318. PubMed ID: 34921468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.
    Montgomery J; Ryan M; Engler R; Hoffman D; McClenathan B; Collins L; Loran D; Hrncir D; Herring K; Platzer M; Adams N; Sanou A; Cooper LT
    JAMA Cardiol; 2021 Oct; 6(10):1202-1206. PubMed ID: 34185045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute cardiac side effects after COVID-19 mRNA vaccination: a case series.
    Freise NF; Kivel M; Grebe O; Meyer C; Wafaisade B; Peiper M; Zeus T; Schmidt J; Neuwahl J; Jazmati D; Luedde T; Bölke E; Feldt T; Jensen BEO; Bode J; Keitel V; Haussmann J; Tamaskovics B; Budach W; Fischer JC; Knoefel WT; Schneider M; Gerber PA; Pedoto A; Häussinger D; van Griensven M; Rezazadeh A; Flaig Y; Kirchner J; Antoch G; Schelzig H; Matuschek C
    Eur J Med Res; 2022 Jun; 27(1):80. PubMed ID: 35655235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of myocarditis and pericarditis after COVID-19 vaccination in children and adolescents: A systematic review.
    Fatima M; Khan MHA; Ali MS; Osama M; Cheema HA; Ahmed A; Nisar A; Murad MW; Farooq H; Aemaz Ur Rehman M; Swed S; Akbar UA
    Clin Cardiol; 2023 Mar; 46(3):243-259. PubMed ID: 36594165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocarditis and pericarditis after COVID-19 messenger RNA vaccines.
    Goldman RD
    Can Fam Physician; 2022 Jan; 68(1):17-18. PubMed ID: 35063975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines.
    Naveed Z; Li J; Wilton J; Spencer M; Naus M; Velásquez García HA; Kwong JC; Rose C; Otterstatter M; Janjua NZ;
    J Am Coll Cardiol; 2022 Nov; 80(20):1900-1908. PubMed ID: 36357091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal relationship of myocarditis and pericarditis following COVID-19 vaccination: A pragmatic approach.
    Anastassopoulou C; Hatziantoniou S; Vlachopoulos C; Spanakis N; Tsioufis C; Tsakris A; Lazaros G
    Int J Cardiol; 2022 Jul; 358():136-139. PubMed ID: 35436559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines.
    Foltran D; Delmas C; Flumian C; De Paoli P; Salvo F; Gautier S; Drici MD; Karsenty C; Montastruc F
    Eur Heart J Qual Care Clin Outcomes; 2022 Mar; 8(2):99-103. PubMed ID: 34849667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines.
    Abraham N; Spruin S; Rossi T; Fireman B; Zafack J; Blaser C; Shaw A; Hutchings K; Ogunnaike-Cooke S
    Vaccine; 2022 Jul; 40(32):4663-4671. PubMed ID: 35750537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature.
    Lane S; Yeomans A; Shakir S
    BMJ Open; 2022 May; 12(5):e059223. PubMed ID: 35613761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination.
    Haaf P; Kuster GM; Mueller C; Berger CT; Monney P; Burger P; Stämpfli SF; Attenhofer Jost CH; Zellweger MJ; Osswald S; Donner BC; Koestner SC; Tanner FC
    Swiss Med Wkly; 2021 Oct; 151():w30087. PubMed ID: 34668687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of myopericarditis following COVID-19 mRNA vaccination in a large integrated health system: A comparison of completeness and timeliness of two methods.
    Sharff KA; Dancoes DM; Longueil JL; Johnson ES; Lewis PF
    Pharmacoepidemiol Drug Saf; 2022 Aug; 31(8):921-925. PubMed ID: 35404496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination - PCORnet, United States, January 2021-January 2022.
    Block JP; Boehmer TK; Forrest CB; Carton TW; Lee GM; Ajani UA; Christakis DA; Cowell LG; Draper C; Ghildayal N; Harris AM; Kappelman MD; Ko JY; Mayer KH; Nagavedu K; Oster ME; Paranjape A; Puro J; Ritchey MD; Shay DK; Thacker D; Gundlapalli AV
    MMWR Morb Mortal Wkly Rep; 2022 Apr; 71(14):517-523. PubMed ID: 35389977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Brighton Collaboration criteria for myocarditis and pericarditis following COVID-19 vaccine in Korean adolescents.
    Lee JS; Choi H; Shin SH; Hwang MJ; Na S; Kim JH; Park S; Yoon Y; Kang HM; Ahn B; Seo K; Choe YJ
    Vaccine; 2024 May; 42(14):3333-3336. PubMed ID: 38604914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.